1,941 reports of this reaction
1.4% of all INFLIXIMAB DYYB reports
#16 most reported adverse reaction
BLOOD PRESSURE FLUCTUATION is the #16 most commonly reported adverse reaction for INFLIXIMAB DYYB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,941 FDA adverse event reports linking INFLIXIMAB DYYB to BLOOD PRESSURE FLUCTUATION. This represents approximately 1.4% of all 142,758 adverse event reports for this drug.
Patients taking INFLIXIMAB DYYB who experience blood pressure fluctuation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD PRESSURE FLUCTUATION is a less commonly reported adverse event for INFLIXIMAB DYYB, but still significant enough to appear in the safety profile.
In addition to blood pressure fluctuation, the following adverse reactions have been reported for INFLIXIMAB DYYB:
The following drugs have also been linked to blood pressure fluctuation in FDA adverse event reports:
BLOOD PRESSURE FLUCTUATION has been reported as an adverse event in 1,941 FDA reports for INFLIXIMAB DYYB. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD PRESSURE FLUCTUATION accounts for approximately 1.4% of all adverse event reports for INFLIXIMAB DYYB, making it a notable side effect.
If you experience blood pressure fluctuation while taking INFLIXIMAB DYYB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.